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Abstract
Background  and  objectives:  Inhalation  anesthetics  are  used  in  human,  as  well  as  veterinary
medical practice.  In  the  present  study  we  investigated  the  effect  of  isoﬂurane  and  sevoﬂurane
on rat  hepatocytes.
Methods:  A  total  of  40  Wistar  female  rats  were  used  in  this  study.  Animals  were  divided  in
groups of  5  rats.  Groups  IM,  SM  served  as  control  groups.  Groups  I1,  I2,  I3  were  used  to  study
isoﬂurane and  S1,  S2,  S3  for  sevoﬂurane  study.  They  were  anesthetized  3  times,  for  2  h  long,  at
2 days  interval  with  a  concentration  of:  1.5%  isoﬂurane  (I1,  I2,  I3)  and  2%  sevoﬂurane  (S1,  S2,
S3). The  oxygen  supply  throughout  the  anesthesia  was  1  L  O2/min.  Groups  IM,  IS,  I1,  S1  were
sacriﬁced  immediately  after  the  last  anesthesia.  Groups  I2,  S2  were  sacriﬁced  6  h  after  the  last
anesthesia,  and  groups  I3,  S3,  24  h  post-anesthesia.  Liver  samples  were  harvested  to  highlight
caspase-3  in  apoptotic  hepatocytes.
Results:  Following  isoﬂurane  administration,  there  were  less  than  1%  cells  in  apoptosis  high-
lighted in  rat  livers  from  groups  IM,  I1  and  I2.  At  24  h  post-anesthesia  (group  I3),  a  small
number  of  apoptotic  hepatocytes  was  highlighted  (around  3.23%  cells  in  apoptosis),  with  a
strictly periacinar  disposition,  randomly  distributed  in  a  small  number  of  hepatic  lobules.  After
sevoﬂurane  administration,  less  than  1%  apoptotic  hepatocytes  were  identiﬁed  at  all  control
moments throughout  the  study. The study was carried out at the Department of Anesthesiology and Surgical Propedeutics, University of Agricultural Sciences and
Veterinary Medicine, Cluj-Napoca, Romania.
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Conclusions:  The  results  suggest  that  the  anesthetics  do  not  present  a  considerable  hepatotox-
icity. The  comparative  assessment  of  the  two  anesthetics  shows  that  sevoﬂurane  is  superior  to
isoﬂurane.
© 2015  Sociedade  Brasileira  de  Anestesiologia.  Published  by  Elsevier  Editora  Ltda.  This  is  an
open access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-
nc-nd/4.0/).
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Avaliac¸ão  imuno-histoquímica  comparativa  do  efeito  da  anestesia  repetitiva
com  isoﬂurano  e  sevoﬂurano  sobre  o  fígado  de  rato
Resumo
Justiﬁcativa  e  objetivos: Anestésicos  inalatórios  são  usados  em  humanos  e  também  na  prática
médica veterinária.  No  presente  estudo  investigamos  o  efeito  de  isoﬂurano  e  sevoﬂurano  em
hepatócitos  de  rato.
Métodos:  No  total,  40  ratos  Wistar  fêmeas  foram  usados  neste  estudo.  Os  animais  foram  dividi-
dos em  grupos  de  cinco  ratos  cada.  Os  grupos  IM  e  SM  serviram  como  grupos  controle.  Os  grupos
I1, I2  e  I3  foram  usados  para  o  estudo  de  isoﬂurano  e  os  grupos  S1,  S2  e  S3  para  o  estudo  de
sevoﬂurano.  Os  ratos  foram  anestesiados  três  vezes,  durante  o  período  de  2  horas  em  intervalos
de dois  dias,  com  uma  concentrac¸ão  de  1,5%  de  isoﬂurano  (I1,  I2,  I3)  e  2%  de  sevoﬂurano  (S1,  S2,
S3). O  fornecimento  de  oxigênio  durante  a  anestesia  foi  de  1  L  O2/min.  Os  grupos  IM,  IS,  I1  e  S1
foram sacriﬁcados  imediatamente  após  a  última  anestesia.  Os  grupos  I2  e  S2  foram  sacriﬁcados
6 horas  após  a  última  anestesia  e  os  grupos  I3  e  S3  foram  sacriﬁcados  24  horas  após  a  anestesia.
Amostras  dos  fígados  foram  colhidas  para  ressaltar  a  caspase-3  em  hepatócitos  apoptóticos.
Resultados:  Após  a  administrac¸ão  de  isoﬂurano,  havia  menos  de  1%  das  células  em  apoptose
em destaque  nos  fígados  dos  ratos  dos  grupos  IM,  I1  e  I2.  Às  24  horas  após  a  anestesia  (grupo
I3), um  pequeno  número  de  hepatócitos  apoptóticos  foi  destacado  (cerca  de  3,23%  de  células
em apoptose),  com  uma  disposic¸ão  estritamente  periacinar,  distribuídos  aleatoriamente  em  um
pequeno número  de  lóbulos  hepáticos.  Após  a  administrac¸ão  do  sevoﬂurano,  menos  de  1%  de
hepatócitos  apoptóticos  foi  identiﬁcado  em  todos  os  momentos  de  controle  ao  longo  do  estudo.
Conclusões:  Os  resultados  sugerem  que  os  anestésicos  não  apresentam  uma  hepatotoxicidade
considerável.  A  avaliac¸ão  comparativa  dos  dois  anestésicos  mostra  que  sevoﬂurano  é  superior
ao isoﬂurano.
© 2015  Sociedade  Brasileira  de  Anestesiologia.  Publicado  por  Elsevier  Editora  Ltda.  Este e´  um
artigo Open  Access  sob  uma  licenc¸a  CC  BY-NC-ND  (http://creativecommons.org/licenses/by-
nc-nd/4.0/).
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nhalational  anesthetics  are  widely  used  in  both  human
nd  veterinary  medicine.  They  can  be  utilized  in  anes-
hetic  management  in  a  large  number  of  species,  including
eptiles,  birds  and  wild  animals.1--5 The  primary  site  for
etabolism  of  inhalational  anesthetics  is  represented  by
he  liver.6,7 Under  these  circumstances,  it  is  possible  that
ome  physiological  or  morphological  changes  appear  in  the
iver,  due  to  either  the  direct  action  of  these  anesthetics  or
ome  intermediary  metabolits  resulted  during  their  degra-
ation.  These  aspects  have  made  the  object  of  numerous
tudies  which  brought  much  useful  information,  but  there
re  still  controversies  surrounding  the  inhalational  anesthet-
cs’  action  on  the  liver.  Thus,  there  are  studies  that  report
 minor  liver  enzymes  elevation,  while  others  report  fulmi-
ant  necrotic  hepatitis,  resulting  even  in  patient’s  death.8--10
The  great  majority  of  the  investigations  have  studied  the
nhalational  anesthetic  effects  on  liver  function.11 Macro  and
specially  microscopic  aspects  were  the  object  of  study  of
p
o
s
a relatively  small  number  of  investigations.  Some  authors
ustain  that  prolonged  anesthesia  with  isoﬂurane  does  not
nduce  hepatic  lesions  in  animals.12--14 Soubhia  et  al.10
valuated  the  transaminase  activity,  and  also  the  liver,  his-
ologically,  after  exposure  to  sevoﬂurane,  recording  slightly
ncreased  values  for  transaminase  activity  and  no  morpho-
ogical  change  of  the  liver  parenchyma  in  light  microscopy.
onda  et  al.15 evaluated  both  liver  function  and  morphology
fter  exposure  to  isoﬂurane  and  sevoﬂurane.  The  conclusion
f  the  study  was  that  the  degree  of  hepatic  lesions  induced
y  isoﬂurane  exposure  was  higher  than  the  one  induced  by
evoﬂurane.  Elena  et  al.16 studied  liver,  kidney  and  spleen
hysiology  and  histology  after  repeated  sevoﬂurane  anes-
hesia.  The  authors  did  not  detect  an  altered  liver  and  renal
unction  or  changes  in  the  architecture  of  these  organs.
ther  authors  report  histopathological  lesions  varying  from
anlobular,  to  multifocal,  even  fulminant  necrosis.17 A case
f  fulminant  liver  failure  was  reported  after  the  third  expo-
ure  to  isoﬂurane,  with  submassive  and  massive  necrosis
t  histopathological  examination.8 Zizek  et  al.9 also  report
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the  organ  and  the  small  number  of  apoptotic  cells,  compara-
ble  to  the  control  group  (i.e.,  less  than  1%  cells  in  apoptosis).
First  noticeable  changes  appear  only  in  group  I3  and  consist
of  the  presence  of  caspase-3  positive  cells  in  some  lobulesComparative  immunohistochemical  assessment  of  the  effect
fatal  subacute  liver  failure,  with  massive  necrosis  of  hepa-
tocytes,  at  repeated  sevoﬂurane  anesthesia.
Considering  the  small  number  of  morphological  investiga-
tions  and  especially  the  conﬂicting  available  information  in
the  specialty  literature,  we  considered  opportune  to  con-
duct  histological  and  immunohistochemical  investigations
regarding  the  isoﬂurane  and  sevoﬂurane  effect  on  rat  liver.
Methods
The  experimental  protocol  was  approved  by  the  Scientiﬁc
Research  Ethics  Committee  of  UASVM  (University  of  Agri-
cultural  Sciences  and  Veterinary  Medicine)  Cluj-Napoca  and
was  conducted  in  accordance  with  the  Ministry  of  Health
force  and  with  the  pertained  European  legislation.  The
experimental  study  was  conducted  in  the  Biobase  of  UASVM
Cluj-Napoca  and  in  the  Department  of  Anesthesiology  and
Surgical  Propedeutics,  UASVM  Cluj-Napoca.
A  total  of  40  6  week-old  Wistar  female  rats  were  used  in
the  experimental  study.  The  rats  were  randomly  divided  in
8  groups,  5  rats  each.  Two  of  them  served  as  control  groups:
IM  (control  isoﬂurane)  and  SM  (control  sevoﬂurane),  rats  in
this  group  being  exposed  to  oxygen  alone  (1  L/min)  3  times,
for  2  h  long,  at  2  days  interval.  Three  groups  (I1,  I2  and  I3)
were  subjected  to  isoﬂurane  anesthesia  at  a  concentration
of  1.5%  and  the  other  three  (S1,  S2  and  S3)  to  sevoﬂurane
at  a  2%  concentration.  At  the  utilized  concentrations,  the
minimum  alveolar  concentration  (MAC)  was  approximately
1  in  the  case  of  isoﬂurane,18 as  well  as  sevoﬂurane.19 The
concentration  of  anesthetic  was  adjusted  by  using  a vapor-
izer.
We  used  an  induction  box  for  anesthesias.  The  rats  were
introduced  in  the  induction  box  15  min  before  initiating  the
anesthesia,  in  order  to  accommodate.  Experimental  groups
were  anesthetised  3  times,  for  2  h  long,  at  2  days  interval.
The  oxygen  supply  throughout  the  anesthesia  was  1  L  O2/min
for  both  isoﬂurane  and  sevoﬂurane.  We  followed  the  pro-
tocol  recommended  by  Honda  et  al.,15 mentioning  that  the
anesthesias  were  repeated  3  times  in  order  to  see  the  effects
of  repeated  anesthesia  with  isoﬂurane  and  sevoﬂurane.
After  completing  the  anesthesias,  the  rats  were  sacriﬁced
through  cervical  dislocation,  at  different  post-anesthetic
times:  groups  IM,  SM,  I1  and  S2  immediately  after  the  anes-
thesia,  groups  I2,  S2  --  6  h  post-anesthesia  and  I3,  S3  groups
--  24  h  post-anesthesia.
Immediately  after  the  euthanasia,  liver  samples  were
harvested,  introduced  in  10%  buffered  formalin  for  ﬁxation.
After  the  ﬁxation  period,  the  samples  were  embedded  in
parafﬁn  and  then  sectioned  at  a  5  m  thickness  and  mounted
on  poly-l-lysine  coated  microscopic  slides  (for  the  immuno-
histochemical  reaction).
In  order  to  detect  the  apoptotic  hepatocytes,  we  used
the  immunohistochemical  reaction  to  highlight  the  caspase-
3  expression,  as  marker  of  programmed  cell  death.  With  this
purpose  in  view,  Leica  Bond-maxTM Immunohostochemistry
system  (Leica  Biosystems  Melbourne,  Bond  Max  model,  M2
12154  series)  was  used.  The  immunomarcation  was  made
with  Rabbit  Anti-Caspase-3  Polyclonal  Antibodies  (dilution
1/75,  rabbit  anti-caspase  3  polyclonal,  Linaris,  Biologische
Produkte,  Dossenheim,  Germany  --  cat.  n◦ RB-1197-R7).  The
steps  taken  by  the  system  in  order  to  stain  the  sections
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ere  the  following:  (a)  deparafﬁnization  and  rinsing  with
n  EDTA  solution  at  8.8  pH  (Epitope  Retrieval  Solution  2),
8 ◦C  for  20  min;  (b)  after  rinsing,  the  DC  9800  kit  was  used
or  10  min  (Leica  Microsystem  GmbH)  in  order  to  block  the
ndogenous  peroxidase;  (c)  rinsing,  after  which  the  ‘‘rabbit
nti-caspase-3’’  primary  antibody  was  added  and  incuba-
ion  for  30  min;  (d)  polymerase  adding  and  incubation  for
0  min,  obtaining  the  color  reaction  with  the  help  of  DAB
diaminobenzidine).
Evaluation  of  the  marker  was  made  through  quantiﬁca-
ion  of  immunomarked  cells.  Cells  with  a  different  intensity
rown  cytoplasm  were  considered  positive.  Immunomarked
ells  from  5  microscopic  ﬁelds,  at  400× magniﬁcation,  were
ounted.  The  following  grading  method  was  used  for  each
ase:  (I)  less  than  1%  cells  in  apoptosis,  (II)  1--2%  cells  in
poptosis,  and  (III)  more  than  2%  cells  in  apoptosis.  The
icroscopic  images  were  obtained  using  the  Olympus  BX51
ight  microscope  connected  to  an  Olympus  DP-25  digital  pho-
ocamera,  images  being  stored  on  a  digital  memory  card  and
hown  on  the  monitor.
esults
mmunohistochemical  reaction  for  caspase-3  highlighted  a
mall  number  of  caspase-3  positive  cells  in  rat  livers  from
roups  IM  and  SM  (i.e.,  less  than  1%  cells  in  apoptosis),  no
ore  that  the  normal  hepatocyte  exchange  rate.  Apart  from
he  fact  they  were  scarce,  the  caspase-3  positive  cells  were
solated  and  scattered  throughout  the  hepatic  lobules.  On
ost  of  the  section  area,  the  hepatic  lobules  had  a normal
tructure  and  did  not  contain  apoptotic  cells  (Fig.  1).
Livers  from  rats  in  I1  group  did  not  present  more  caspase-
 positive  cells  than  the  control  group  (i.e.,  less  than  1%
ells  in  apoptosis),  so  that  in  the  great  majority  of  the  lob-
les  they  were  not  present,  not  even  isolated.  The  situation
aintains  in  I2  group,  regarding  both  the  general  aspect  ofigure  1  Control  group  --  no  apoptotic  cells;  immunohisto-
hemical  reaction  anti-caspase-3  polyclonal  antibodies,  Mayer
ematoxylin  counterstain.
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Figure  2  Experimental  group  I3  --  centrilobular  distributed
apoptotic  cells  (suggested  by  a  darker  cytoplasm)  --  black
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errows;  immunohistochemical  reaction  anti-caspase-3  poly-
lonal antibodies,  Mayer  hematoxylin  counterstain.
around  3.23%  cells  in  apoptosis,  which  represent  more  than
%  cells  in  apoptosis  according  to  the  suggested  grading
ethod).  Some  of  the  cells  in  the  close  vicinity  of  the  cen-
rilobular  vein  appear  affected  (Fig.  2).  We  mention  that  the
henomenon  is  not  present  in  all  of  the  hepatic  lobules,  but
nly  in  some  of  them.  There  were  no  inﬂammatory  changes
r  circulatory  disorders  observed  after  exposure  of  the  rats
o  isoﬂurane.
In  the  livers  harvested  from  rats  in  group  S1,  the  situation
s  comparable  to  the  one  in  the  control  group,  the  number  of
aspase-3  positive  cells  being  very  small.  A  major  increase
f  the  caspase-3  positive  cells  is  noticed  in  neither  S2,  nor
3  groups.  No  other  associated  lesions  were  observed  (e.g.,
ystrophic,  inﬂammatory  lesions  or  circulatory  disorders)  in
he  liver  after  exposure  of  the  subjects  to  sevoﬂurane.
iscussion
ivers  from  rats  in  the  control  groups  presented  a  normal
spect  regarding  the  lobulation  and  the  lobular  pattern.
aspase-3  positive  cells  (i.e.,  in  apoptosis)  were  identiﬁed,
ut  their  number  was  small,  actually  representing  the  nor-
al  hepatocyte  exchange  rate  (aspect  suggested  by  the
solated  disposition,  scattered  throughout  the  hepatic  lob-
les,  with  numerous  hepatic  lobules  without  immunomarked
ells).
Livers  from  rats  in  group  I1  were  comparable  to  the  ones
rom  rats  in  the  control  group,  from  all  points  of  view.
aspase-3  positive  cells  were  present  in  small  numbers  and
nly  in  some  lobules,  so  that  we  cannot  state  that  after  the
nesthetic  administration  there  were  immediate  adverse
eactions,  not  even  discrete  ones.  In  group  I2,  no  changes
ere  observed  regarding  the  apoptoses’  distribution  in  liver
n  comparison  to  the  two  groups  presented  anteriorly.  In
roup  I3  a  slight  increase  of  the  number  of  caspase-3  posi-
ive  cells  was  observed,  in  comparison  to  the  control,  I1  and
2  groups.  Comparative  to  the  things  observed  in  group  IM,  I1
nd  I2,  in  the  case  of  subjects  from  group  I3  a  larger  number
f  immunomarked  cells  (in  apoptosis)  was  identiﬁed,  focally
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isposed,  prevailingly  centroacinar.  A  possible  explanation
f  the  affectation  of  the  cells  in  the  immediate  vicinity  of
he  centrilobular  vein  could  be  the  fact  that  the  anesthetic
eaches  the  liver  through  the  circulatory  system,  but  in  this
ituation,  hepatocytes  at  the  periphery  of  the  lobules  should
e  the  ﬁrst  cells  to  give  in,  because  that  is  the  place  that
he  sinusoids  enter  the  hepatic  lobules.  But  hepatocytes  at
he  periphery  of  the  lobules  are  favored  in  terms  of  nutrient
nd  oxygen  supplies,  being  the  ﬁrst  to  beneﬁt  due  to  their
isposal,  which  seems  to  confer  resistance  to  the  anesthetic
ction.  Cells  in  the  vicinity  of  the  centrilobular  vein  are  the
ast  to  supply.  Apparently,  this  makes  them  somewhat  vul-
erable,  some  of  them  entering  apoptosis  under  anesthetic
ction.  Other  reports  suggest  that  the  periacinar  zone  is  par-
icularly  vulnerable  to  apoptosis/necrosis  (known  as  zone  3
r  periacinar  apoptosis/necrosis),  partly  because  they  are
arthest  from  incoming  arterial  and  portal  venous  blood,
earing  oxygen  and  essential  nutrients.20,21
However,  the  number  of  apoptotic  cells  is  so  small;  we
an  state  that  isoﬂurane  is  an  anesthetic  with  a  good  tol-
rance.  The  adverse  reactions  appeared  in  the  liver  after
ts  administration  in  therapeutic  dose  is  minimal,  without
ther  cellular  lesions  (e.g.,  dystrophies,  necroses,  vascu-
ar  disorders)  that  induce  changes  in  the  pattern  of  the
rgan.
Sevoﬂurane  administration  did  not  result  in  the  increas-
ng  of  caspase-3  positive  hepatocyte  number  in  experimental
roups  immediately  after  the  anesthesia  or  the  other  con-
rol  times  (6  h  and  24  h  post-anesthesia).  At  none  of  these
oments,  the  caspase-3  positive  cells  were  at  such  a  level
hich  would  suggest  that  the  anesthetic  would  trigger  hepa-
ocyte  apoptosis.  Apoptoses  were  present  in  a  small  number
f  cells,  somehow  comparable  in  all  groups,  which  makes  us
tate  that  their  presence  is  absolutely  normal,  being  linked
o  the  normal  hepatocyte  exchange  rate.  In  other  terms,
evoﬂurane  does  not  seem  to  have  adverse  reactions  on
at  liver,  detectable  through  histological  examination.  This
emonstrates  a  very  good  tolerability  of  sevoﬂurane  in  the
iver.
The  comparative  assessment  of  the  effect  of  the  two
nesthetics  on  rat  liver  highlights  the  fact  that  although
oth  are  well  tolerated,  at  least  at  the  dose  and  dura-
ion  of  administration  chosen  by  us  in  this  experimental
rotocol,  there  are  certain  differences  between  them.
hese  differences  refer  to  the  fact  that  although  isoﬂurane
resents  a  good  tolerance,  it  triggered  apoptosis  in  a  rel-
tively  small  number  of  hepatocytes,  whereas  sevoﬂurane
id  not.  Although  the  differences  are  minimal,  the  fact  that
evoﬂurane  presents  a superior  tolerability  in  comparison
o  isoﬂuran  stands  out.  In  this  regard,  our  results  are  con-
istent  with  the  reports  of  Nishiyama  et  al.,22 Nishiyama23
ho  state  that  the  degree  of  the  hepatic  lesions  induced
y  isoﬂurane  exposure  was  greater  than  the  one  induced  by
evoﬂurane.  Honda  et  al.15 make  comparable  statements,
ut  the  authors  mentioned  above  were  referring  to  other
ypes  of  hepatic  lesions,  not  apoptosis.  Moreover,  they  state
hat  they  did  not  observe  apoptosis  from  0  h  to  day  7  after
xposure  to  isoﬂurane  or  sevoﬂurane,  by  using  rabbit  anti-
sDNA  polyclonal  antibodies.  The  explanation  given  by  them
s  the  fact  that  the  results  seem  to  have  been  inﬂuenced
y  the  dose,  which,  according  to  them,  might  have  been
oo  large  to  allow  apoptosis.  The  statement  seems  correct,
 of  r
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2Comparative  immunohistochemical  assessment  of  the  effect
knowing  that  necrosis  appears  when  the  hypoxia  is  severe,
while  apoptosis  takes  place  when  the  hypoxia  is  mild.24
The  exact  path  of  apoptosis  induction  by  inhalational
anesthetics  is  not  entirely  known,  but  there  are  studies
which  propose  different  hypotheses.  Thus,  Zhang  et  al.25
have  shown  that  2%  isoﬂurane  treatment  for  6  h  long  can
cause  apoptosis.  Their  study  was  conducted  on  cell  cul-
tures,  primary  neurons  and  mice.  They  stated  that  isoﬂurane
can  increase  the  pro-apoptotic  Bax  factor  level,  decrease
the  anti-apoptotic  Bcl-2  factor  level,  increase  the  accu-
mulation  of  reactive  oxygen  species,  enable  the  release  of
cytochrome  c  from  mitochondria  in  cytosol  and  induce  the
activation  of  caspase-9  and  caspase-3,  thus  inducing  apo-
ptosis  through  Bcl-2  protein  family  and  mitochondrial  path.
Wei  et  al.26 propose  another  hypothesis:  activation  of
inositol  1,4,5-triphosphate  (IP3)  receptors  on  the  endoplas-
mic  reticulum  membranes  by  isoﬂurane.  This  fact  causes
the  excessive  release  of  calcium,  triggering  apoptosis.
The  authors  specify  that  isoﬂurane  induced  apoptosis,
dependent  on  the  anesthetic  concentration  and  duration,
increasing  the  cytosolic  and  then  the  mitochondrial  cal-
cium.  Turrilazzi  et  al.27 report  a  case  of  fatal  fulminant
hepatic  necrosis  after  sevoﬂurane  anesthesia,  incriminating
the  cytoplasmic  calcium  increase  by  sevoﬂurane  as  cause.
In  conclusion,  our  results  show  that  sevoﬂurane  does
not  trigger  hepatocyte  apoptosis,  whereas  isoﬂurane  deter-
mines  a  moderate  inconstant  periacinar  apoptosis,  24  h
post-anesthesia.  Our  results  suggest  that  the  tested
anesthetics  do  not  present  a  signiﬁcant  hepatotoxicity,
sevoﬂurane  proving  to  have  a  superior  tolerability  in  com-
parison  to  isoﬂurane.
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